In December 2019 the United Kingdom Anti-Doping (UKAD) has reported an anti-doping rule violation against the Boxer Bradley Watson after his sample tested positive for the prohibited substancd Clomifene. After notification the Athlete gave a prompt admission, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by UKAD.
The Athlete explained that he had used the substance for the purpose of self-medicating as treatment for his medical condition. UKAD accepts that the Athlete’s violation was not intentional and considers that the Athlete gave a prompt admission.
Without grounds for No Significant Fault or Negligence UKAD decides on 13 July 2020 to impose a 2 year period of ineligibility on the Athlete starting on the date of sample collection, i.e. on 28 September 2019.
